AvKARE 2026-03-04 Health serious FDA
Health · FDA · Recall #FDA-D-0341-2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only,… Recall
Issued March 4, 2026 · AvKARE
In March 2026, AvKARE recalled the Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
What you should do
- 1 Stop using Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact AvKARE to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- AvKARE
- Category
- Health
- Recall date
- March 4, 2026
- Units affected
- Not reported
- Sold at
- Nationwide in the USA.
- Recall number
- FDA-D-0341-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- AvKARE has 10 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.